Device and method to reduce artifact from tissue conduction communication transmission

US11213684B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11213684-B2
Application numberUS-201816203939-A
CountryUS
Kind codeB2
Filing dateNov 29, 2018
Priority dateNov 29, 2017
Publication dateJan 4, 2022
Grant dateJan 4, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A device is configured to transmit tissue conductance communication (TCC) signals by generating multiple TCC signals by a TCC transmitter of the IMD. The generated TCC signals are coupled to a transmitting electrode vector via a coupling capacitor to transmit the plurality of TCC signals to a receiving medical device via a conductive tissue pathway. A voltage holding circuit holds the coupling capacitor at a DC voltage for a time interval between two consecutively transmitted TCC signals.

First claim

Opening claim text (preview).

What is claimed is: 1. A device comprising: a housing; and a tissue conduction communication (TCC) transmitter enclosed by the housing and configured to generate a plurality of TCC signals, each of the plurality of TCC signals comprising a plurality of cycles of a carrier frequency signal, the TCC transmitter comprising: a coupling capacitor for coupling the generated TCC signals to a transmitting electrode vector to transmit the plurality of TCC signals via a conductive tissue pathway; and a voltage holding circuit configured to hold the coupling capacitor at a direct current (DC) voltage for a time interval between two consecutively transmitted TCC signals of the plurality of TCC signals. 2. The device of claim 1 , wherein: the voltage holding circuit comprises at least one switch connecting the coupling capacitor to the transmitting electrode vector; the TCC transmitter comprises a controller configured to control the voltage holding circuit to hold the coupling capacitor at the DC voltage by: opening the at least one switch after a first of the two consecutively transmitted TCC signals, and closing the at least one switch at a start of a second of the two consecutively transmitted TCC signals. 3. The device of claim 2 , wherein: the voltage holding circuit comprises at least two switches, a first switch connecting the coupling capacitor to a source of the TCC signal and a second switch connecting the coupling capacitor to the transmitting electrode vector; the TCC transmitter comprises a controller configured to control the voltage holding circuit to hold the coupling capacitor at the DC voltage by: opening the first and second switch after a first of the two consecutively transmitted TCC signals to float the coupling capacitor, and closing the first and second switch at a start of a second of the two consecutively transmitted TCC signals. 4. The device of claim 1 , wherein the voltage holding circuit is further configured to: determine the DC voltage by detecting a voltage across the coupling capacitor; and apply the determined DC voltage across the coupling capacitor for the time interval between the two consecutively transmitted TCC signals. 5. The device of claim 4 , wherein the voltage holding circuit comprises: an analog-to-digital converter configured to determine the DC voltage; and a digital-to-analog converter to receive the DC voltage from the analog-to-digital converter and apply the DC voltage across the coupling capacitor. 6. The device of claim 5 , wherein the voltage holding circuit further comprises a resistor coupled to the digital-to-analog converter and the digital-to-analog converter applies the DC voltage through the resistor. 7. The device of claim 1 , further comprising: a sensing circuit configured to receive a cardiac electrical signal from a patient's heart; and a control circuit configured to: apply a blanking period to the sensing circuit; and control the TCC transmitter to start transmitting at least a first one of the plurality of TCC signals during the blanking period. 8. The device of claim 7 , wherein: the voltage holding circuit is configured to hold the coupling capacitor at the DC voltage for the time interval by holding the coupling capacitor at the DC voltage after a last TCC signal of a first transmission session until a first TCC signal of a second transmission session; and the control circuit is configured to control the TCC transmitter to start transmitting the first TCC signal of the second transmission session outside a second blanking period applied to the sensing circuit. 9. The device of claim 1 , wherein the voltage holding circuit is configured to hold the coupling capacitor at the DC voltage for the time interval by holding the coupling capacitor at the DC voltage after a last TCC signal of a first transmission session until a first TCC signal of a second transmission session. 10. The device of claim 1 , further comprising a control circuit configured to: identify a physiological refractory period associated with one of an intrinsic or evoked cardiac event; and control the TCC transmitter to start transmitting a first one of the plurality of TCC signals during the physiological refractory period. 11. The device of claim 1 , wherein the voltage holding circuit is configured to hold the coupling capacitor within five percent (5%) of the DC voltage. 12. The device of claim 1 , wherein: the TCC transmitter includes a drive signal source and a polarity switching circuit configured to generate the plurality of TCC signals by generating the carrier frequency signal and modulating the carrier frequency signal, wherein the carrier frequency signal charges the coupling capacitor to the DC voltage during a first one of the plurality of TCC signals; and the voltage holding circuit is configured to hold the coupling capacitor at the DC voltage by: disconnecting the coupling capacitor between the polarity switching circuit and the electrode vector during a voltage holding interval between each of the plurality of TCC signals; and during each of the voltage holding intervals, hold the coupling capacitor at a DC voltage established on the coupling capacitor during an immediately preceding one of the plurality of TCC signals. 13. A method comprising: generating a plurality of tissue conduction communication (TCC) signals, each of the plurality of TCC signals comprising a plurality of cycles of a carrier frequency signal; coupling the plurality of generated TCC signals to a transmitting electrode vector via a coupling capacitor to transmit the plurality of TCC signals via a conductive tissue pathway; and holding the coupling capacitor at a direct current (DC) voltage for a time interval between two consecutively transmitted TCC signals of the plurality of TCC signals. 14. The method of claim 13 , wherein holding the coupling capacitor at the DC voltage comprises: after a first of the two consecutively transmitted TCC signals, opening at least one switch that connects the coupling capacitor to the transmitting electrode vector, and closing the at least one switch at a start of the second of the two consecutively transmitted TCC signals. 15. The method of claim 13 , wherein holding the coupling capacitor at the DC voltage comprises: after a first of the two consecutively transmitted TCC signals, opening a first switch connecting the coupling capacitor to a source of the TCC signal and a second switch connecting the coupling capacitor to the transmitting electrode vector; closing the first and second switch at a start of a second of the two consecutively transmitted TCC signals. 16. The method of claim 13 , further comprising: determining the DC voltage by detecting a voltage across the coupling capacitor; and applying the determined DC voltage across the coupling capacitor for the time interval between the two consecutively transmitted TCC signals. 17. The method of claim 16 , further comprising determining the DC voltage with an analog-to-digital converter; receiving the determined DC with a digital-to-analog converter; and applying DC voltage across the coupling capacitor with the digital-to-analog converter. 18. The method of claim 17 , further comprising applying the DC voltage to the coupling capacitor through a resistor coupled to the digital-to-analog converter. 19. The method of claim 13 , further comprising: receiving a cardiac electrical signal with a sensing circuit; applying a blanking period to the sensing circuit; an

Assignees

Inventors

Classifications

  • Communication to several implantable medical devices within one patient · CPC title

  • in combination with another heart therapy · CPC title

  • Body tissue as transmission medium, i.e. transmission systems where the medium is the human body · CPC title

  • Permanently implanted devices, e.g. pacemakers, other stimulators, biochips (A61B5/6861 takes precedence) · CPC title

  • Transmission systems in which the medium consists of the human body · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11213684B2 cover?
A device is configured to transmit tissue conductance communication (TCC) signals by generating multiple TCC signals by a TCC transmitter of the IMD. The generated TCC signals are coupled to a transmitting electrode vector via a coupling capacitor to transmit the plurality of TCC signals to a receiving medical device via a conductive tissue pathway. A voltage holding circuit holds the coupling …
Who is the assignee on this patent?
Medtronic Inc
What technology area does this patent fall under?
Primary CPC classification A61N1/37288. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).